| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/ENE.12845 |
| P698 | PubMed publication ID | 26493280 |
| P2093 | author name string | K Abe | |
| K Sato | |||
| Y Ohta | |||
| Y Fukui | |||
| T Yamashita | |||
| S Kono | |||
| K Deguchi | |||
| N Hishikawa | |||
| P2860 | cites work | Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 |
| Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population | Q33603540 | ||
| Insulin resistance predicts brain amyloid deposition in late middle-aged adults. | Q34429975 | ||
| Risk of dementia in diabetes mellitus: a systematic review | Q36345254 | ||
| Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults | Q36560342 | ||
| Depression: an important comorbidity with metabolic syndrome in a general population | Q36975730 | ||
| Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study | Q37022797 | ||
| Depressive symptoms and metabolic syndrome: is inflammation the underlying link? | Q37052593 | ||
| Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum | Q38236056 | ||
| Metabolic syndrome and risk of dementia in older adults | Q43096515 | ||
| Treatment of vascular risk factors is associated with slower decline in Alzheimer disease | Q46090621 | ||
| Cognitive impairment and frontal-subcortical geriatric syndrome are associated with metabolic syndrome in a stroke-free population. | Q48424996 | ||
| Symptom dimensions of depression and anxiety and the metabolic syndrome | Q48925066 | ||
| Associations between anxiety, depression, and the metabolic syndrome. | Q50898391 | ||
| Association of metabolic syndrome with Alzheimer disease: a population-based study. | Q53280954 | ||
| Computerized touch-panel screening tests for detecting mild cognitive impairment and Alzheimer's disease. | Q53363523 | ||
| P433 | issue | 2 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| metabolic syndrome | Q657193 | ||
| P304 | page(s) | 339-345 | |
| P577 | publication date | 2015-10-23 | |
| P1433 | published in | European Journal of Neurology | Q15757256 |
| P1476 | title | Cognitive and affective functions in Alzheimer's disease patients with metabolic syndrome | |
| P478 | volume | 23 |
| Q50072374 | Advances and insights into neurological practice 2016-17. |
| Q46646567 | Alzheimer's Disease as the Product of a Progressive Energy Deficiency Syndrome in the Central Nervous System: The Neuroenergetic Hypothesis |
| Q47408666 | Alzheimer’s Disease, Brain Injury, and C.N.S. Nanotherapy in Humans: Sonoporation Augmenting Drug Targeting |
| Q46184142 | Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores. |
| Q29994589 | Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential |
| Q48043052 | Comprehensive effects of galantamine and cilostazol combination therapy on patients with Alzheimer's disease with asymptomatic lacunar infarction |
| Q47781003 | Different clinical effect of four antidementia drugs for Alzheimer's disease patients depending on white matter severity |
| Q47630615 | Does metabolic syndrome impact cognition and emotion in Alzheimer's disease? |
| Q38934118 | Factors related to continuous and discontinuous attendance at memory clinics |
| Q38937412 | High BMI levels associate with reduced mRNA expression of IL10 and increased mRNA expression of iNOS (NOS2) in human frontal cortex |
| Q54961329 | Metabolic Syndrome and cognitive decline in the elderly: A systematic review. |
| Q34552380 | Pharmacological and Nonpharmacological Treatment for Apathy in Alzheimer Disease : A systematic review across modalities |
| Q58103524 | Risk of dementia associated with cardiometabolic abnormalities and depressive symptoms: A longitudinal cohort study using the English Longitudinal Study of Ageing |
| Q92144882 | Targeting Early Dementia: Using Lipid Cubic Phase Nanocarriers to Cross the Blood⁻Brain Barrier |
| Q46245383 | Therapeutic effects of drug switching between acetylcholinesterase inhibitors in patients with Alzheimer's disease |
| Q42748376 | Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach |
Search more.